Filter
170
Text search:
vaccination
pan
Featured
Recommendations
19
New Publications
35
Language
Document type
No document type
62
Studies & Reports
38
Guidelines
32
Strategic & Response Plan
13
Fact sheets
9
Manuals
8
Training Material
2
Brochures
2
Situation Updates
2
Resource Platforms
2
Countries / Regions
Latin America and the Carribbean
21
Global
12
Brazil
11
Venezuela
6
South Africa
5
Colombia
5
Western and Central Europe
5
Haiti
3
Syria
3
Kenya
3
Congo, Democratic Republic of
2
Cameroon
2
Zimbabwe
2
Bangladesh
2
Papua New Guinea
2
Namibia
2
Peru
2
Eastern Europe and Central Asia
2
Africa
2
Guinea
1
Burkina Faso
1
Sierra Leone
1
Nigeria
1
Mali
1
Ghana
1
India
1
Pakistan
1
South Sudan
1
Zambia
1
Mozambique
1
Argentina
1
Honduras
1
Ecuador
1
Bolivia
1
Chile
1
West and Central Africa
1
Eastern Europe
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
52
Clinical Guidelines
27
Women & Child Health
12
Public Health
10
Key Resources
5
Pharmacy & Technologies
2
Toolboxes
COVID-19
42
AMR
10
NTDs
10
HIV
7
Ebola & Marburg
5
Planetary Health
5
Health Financing Toolbox
5
Rapid Response
4
TB
4
Malaria
4
Zika
3
Mental Health
3
Caregiver
3
Cholera
2
Conflict
2
Natural Hazards
2
Refugee
2
Polio
1
Typhoon
1
Global Health Education
1
Pharmacy
1
NCDs
1
2.0 Rapid Response
1
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the neners. This new guide updates the 2006 edition
...
Working document from an informal consultation of experts. A Protocol for risk assessment at the field level. The purpose of document is to provide guidance on the methodology to be used for assessing, at field level, the yellow fever virus circulation in areas at risk, and is primarily intended fo
...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2
...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm
...
This publication is a compendium of 49 country examples highlighting efforts in improving refugees’ and migrants’ health following the adoption of the WHO Global Action Plan on Promoting the health of refugees and migrants at the seventy-second World Health Assembly, in May 2019.
Update 2021; Immunization, Vaccines and Biologicals
Human rabies remains a significant public health problem in Africa with outbreaks reported in most countries. In Nigeria–the most populous country in Africa–rabies causes a significant public health burden partly due to perennial obstacles to implementing a national prevention and control progra
...
Financing Global Health 2016: Development Assistance, Public and Private Health Spending for the Pursuit of Universal Health Coverage presents a complete analysis of the resources available for health in 184 countries, with a particular focus on development assistance for health (DAH). DAH was estim
...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
Rabies is a global public health problem with important socioeconomic impacts. Human rabies is preventable; almost all cases are transmitted through the bite of a rabid dog. Elimination of human rabies is possible. Technical support and tools are available. This report covers:
- Why investment ...
- Why investment ...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si
...
14 January 2021
This practical guide can be used to help countries monitor and analyse the impact of COVID-19 on essential health services to inform planning and decision-making. It provides practical recommendations on how to use key performance indicators to analyse changes in access to and deliv
...